Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.

Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W.

Elife. 2012 Nov 13;1:e00049. doi: 10.7554/eLife.00049. Erratum in: Elife. 2014;3:e05570.

2.

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.

Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W.

Elife. 2012 Nov 13;3. doi: 10.7554/eLife.00049.

3.

Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.

Yan H, Peng B, Liu Y, Xu G, He W, Ren B, Jing Z, Sui J, Li W.

J Virol. 2014 Mar;88(6):3273-84. doi: 10.1128/JVI.03478-13. Epub 2014 Jan 3.

4.

Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.

Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Fälth M, Stindt J, Königer C, Nassal M, Kubitz R, Sültmann H, Urban S.

Gastroenterology. 2014 Apr;146(4):1070-83. doi: 10.1053/j.gastro.2013.12.024. Epub 2013 Dec 19.

PMID:
24361467
5.

Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide.

Yan H, Peng B, He W, Zhong G, Qi Y, Ren B, Gao Z, Jing Z, Song M, Xu G, Sui J, Li W.

J Virol. 2013 Jul;87(14):7977-91. doi: 10.1128/JVI.03540-12. Epub 2013 May 15.

6.

Woodchuck sodium taurocholate cotransporting polypeptide supports low-level hepatitis B and D virus entry.

Fu L, Hu H, Liu Y, Jing Z, Li W.

Virology. 2017 May;505:1-11. doi: 10.1016/j.virol.2017.02.006. Epub 2017 Feb 14.

PMID:
28213271
7.

Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.

Nkongolo S, Ni Y, Lempp FA, Kaufman C, Lindner T, Esser-Nobis K, Lohmann V, Mier W, Mehrle S, Urban S.

J Hepatol. 2014 Apr;60(4):723-31. doi: 10.1016/j.jhep.2013.11.022. Epub 2013 Dec 1.

PMID:
24295872
8.

Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus.

Yan H, Li W.

Dig Dis. 2015;33(3):388-96. doi: 10.1159/000371692. Epub 2015 May 27.

PMID:
26045274
9.

Getting to grips with hepatitis.

Chen ZJ, Ye J.

Elife. 2012 Nov 13;1:e00301. doi: 10.7554/eLife.00301.

10.

NTCP opens the door for hepatitis B virus infection.

Yan H, Liu Y, Sui J, Li W.

Antiviral Res. 2015 Sep;121:24-30. doi: 10.1016/j.antiviral.2015.06.002. Epub 2015 Jun 10. Review.

PMID:
26071008
11.

Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.

König A, Döring B, Mohr C, Geipel A, Geyer J, Glebe D.

J Hepatol. 2014 Oct;61(4):867-75. doi: 10.1016/j.jhep.2014.05.018. Epub 2014 May 15.

12.

Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.

He W, Cao Z, Mao F, Ren B, Li Y, Li D, Li H, Peng B, Yan H, Qi Y, Sun Y, Wang F, Sui J, Li W.

J Virol. 2016 Sep 12;90(19):8866-74. doi: 10.1128/JVI.00901-16. Print 2016 Oct 1.

13.

Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes.

Zhong G, Yan H, Wang H, He W, Jing Z, Qi Y, Fu L, Gao Z, Huang Y, Xu G, Feng X, Sui J, Li W.

J Virol. 2013 Jun;87(12):7176-84. doi: 10.1128/JVI.03533-12. Epub 2013 Apr 17.

14.

HBV life cycle is restricted in mouse hepatocytes expressing human NTCP.

Li H, Zhuang Q, Wang Y, Zhang T, Zhao J, Zhang Y, Zhang J, Lin Y, Yuan Q, Xia N, Han J.

Cell Mol Immunol. 2014 Mar;11(2):175-83. doi: 10.1038/cmi.2013.66. Epub 2014 Feb 10.

15.

From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptor.

Li J, Tong S.

Clin Mol Hepatol. 2015 Sep;21(3):193-9. doi: 10.3350/cmh.2015.21.3.193. Epub 2015 Sep 30. Review.

16.

Interleukin 6 inhibits HBV entry through NTCP down regulation.

Bouezzedine F, Fardel O, Gripon P.

Virology. 2015 Jul;481:34-42. doi: 10.1016/j.virol.2015.02.026. Epub 2015 Mar 9.

17.

A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.

Kaneko M, Watashi K, Kamisuki S, Matsunaga H, Iwamoto M, Kawai F, Ohashi H, Tsukuda S, Shimura S, Suzuki R, Aizaki H, Sugiyama M, Park SY, Ito T, Ohtani N, Sugawara F, Tanaka Y, Mizokami M, Sureau C, Wakita T.

J Virol. 2015 Dec;89(23):11945-53. doi: 10.1128/JVI.01855-15. Epub 2015 Sep 16.

18.

Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.

He W, Ren B, Mao F, Jing Z, Li Y, Liu Y, Peng B, Yan H, Qi Y, Sun Y, Guo JT, Sui J, Wang F, Li W.

PLoS Pathog. 2015 Apr 22;11(4):e1004840. doi: 10.1371/journal.ppat.1004840. eCollection 2015 Apr.

19.

Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.

Iwamoto M, Watashi K, Tsukuda S, Aly HH, Fukasawa M, Fujimoto A, Suzuki R, Aizaki H, Ito T, Koiwai O, Kusuhara H, Wakita T.

Biochem Biophys Res Commun. 2014 Jan 17;443(3):808-13. doi: 10.1016/j.bbrc.2013.12.052. Epub 2013 Dec 14.

20.

Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).

Veloso Alves Pereira I, Buchmann B, Sandmann L, Sprinzl K, Schlaphoff V, Döhner K, Vondran F, Sarrazin C, Manns MP, Pinto Marques Souza de Oliveira C, Sodeik B, Ciesek S, von Hahn T.

PLoS One. 2015 Feb 3;10(2):e0117152. doi: 10.1371/journal.pone.0117152. eCollection 2015.

Supplemental Content

Support Center